Biopharmaceutical company Clovis Oncology, backed by Pfizer, sells the shares following its initial public offering in November last year.

Imaxio, which was created partly from a spin-off from the Medical Research Council and Cambridge University in the UK, raises extra funds.

Three Blue healthcare plans partner with venture-backed healthcare technology company Lumeris to buy real time communication network Navinet, backed by GE Equities.

The US-based oxygen therapy equipment and services raises the funds in a Novo-led round taking it to about $90m raised, based on Global Corporate Venturing analysis.

Google Ventures' Krishna Yeshwant said the investment in the pharmaceutical research and discovery software company comes at a time the pharmaceutical industry "is going through one of the most dramatic transformations in its history".

DBV Technologies, a France-based allergy treatment company, which was the first deal done by Shire Therapeutics' corporate venturing unit, also secures its first portfolio company flotation in Paris.

The maker of electrocardiographic mapping technology, a spin-out from Case Western Reserve University, appoints Bullock to role a month after a $7.5m funding round, as executive chairman Steve Arless leaves.

The drug development company backed by Ucyclyd, part of Medicis Pharmaceutical Corporation, is looking to raise the funds as it seeks Food and Drug Administration approval for its main product.

The maker of electrocardiographic mapping technology, backed by Japan-based distributor of cardiovascular devices DVX, appoints Bullock to role a month after a $7.5m funding round, as executive chairman Steve Arless leaves.